Anemia pada Penyakit Keganasan Anak

Nababan Rouli, Pustika Amalia

Sari


Anemia merupakan komplikasi yang paling sering terjadi pada penyakit keganasan.
Mekanismenya sangat kompleks, yaitu anemia dapat terjadi sebagai dampak langsung
dari penyakit keganasan atau akibat dari pengobatannya. Angka kejadian anemia pada
pasien dengan penyakit keganasan berkisar antara 35% hingga 95% bergantung pada
jenis penyakit keganasan dan regimen kemoterapi yang dipakai. Radioterapi dan
kemoterapi seperti cisplatin, etoposid, dan kombinasi dari siklofosfamid, metotreksat
dan 5-fluorourasil terbukti dapat menyebabkan anemia derajat sedang sampai berat,
oleh sebab itu anemia pada pasien keganasan sangat membutuhkan penanganan yang
baik karena dapat mempengaruhi proses pengobatan, dan kualitas hidup.


Kata Kunci


anemia; keganasan; hemoglobin; eritropoietin; dan terapi

Teks Lengkap:

PDF

Referensi


Conrad ME. Anemia. www.emedicine.com. Diakses

tanggal 10 Februari 2004.

Abrahamian FM, Wilke E. Anemia, chronic.

www.emedicine.com. Diakses tanggal 10 Februari 2004.

Frenkel EP, Bick RL, Rutherford CJ. Anemia of malignancy.

Hematol Oncol Clin North Am 1996;10:861-

Gordon MS. Managing anemia in the cancer patient:

old problems, future solutions. Oncologist 2002;7:331-

Moliterno AR, Spivak JL. Anemia of cancer. Hematol

Oncol Clin North Am 1996;10:345-63.

Armstrong J, Hurria A, Hudis C. Cancer and treatmentrelated

anemia: understanding and interpreting the latest

anemia guidelines. www.medscape.com. Diakses

tanggal 15 Februari 2004.

Young G, Toretsky JA, Campbell AB, Eskenazi AE.

Recognition of common childhood malignancies.

www.aafp.org. Diakses tanggal 1 April 2004.

Kupfer GM. Childhood cancer, epidemiology.

www.emedicine.com. Diakses tanggal 4 Juni 2004.

Gillespie TW. Anemia in cancer: therapeutic implications

and interventions. Cancer Nurs 2003;26(2):119-

Anemia & cancer. Dalam: Anemia a hidden epidemic.

www.anemia.org. Diakses tanggal 15 Februari 2004.

Ludwig H. Epoetin in cancer-related anaemia. Nephrol

dial transplant 1999;14(suppl 2):85-92.

Corazza F, Beguin Y, Bergmann P, Andre M, Ferster A,

Devalck C, dkk. Anemia in children with cancer is associated

with decreases erythropoietic activity and not with

adequate erythropoietin production. Blood 1998;

:1793-8.

Dicato M. Anemia in cancer: some pathophysiologi aspects.

Oncologist 2003; 8(suppl 1):19-21.

Harrison LB, Shasha D, White C, Ramdeen B. Radiotherapy-

associated anemia: the scope of the problem.

Oncologist 2000; 5(suppl 2):1-7.

Saba HI. Anemia in cancer patients: introduction and

overview. www.moffitt.usf.edu/pubs/ccj/v5ns/toc.html.

Diakses tanggal 15 Februari 2004.

Spivak JL. The physiologic basis for the pharmacologic use

of recombinan erythropoietin. www.moffitt.usf.edu/pubs/ccj/

v5ns/article5.html. Diakses tanggal 15 Februari 2004.

Bron D, Meuleman N, Mascaux C. Biological Basis of

Anemia. Semin Oncol 2001; 28(suppl 8):1-6.

Kim MH, Lee JH, Wu CW, Cho SW, Lee KC. Defective

erythropoiesis in bone marrow is a mechanism of

anemia in children with cancer. J Korean Med Sci 2002;

:337-40.

Lanzkowsky P. Hematologic manifestations of systemic

diseases. Dalam: Manual of pediatric hematology and

oncology. Edisi kedua. New York: Churchill livingstone;

h. 63-76.

Varan A, Buyukpamukcu M, Kutluk T, Akyuz C. Recombinant

human erythropoietin treatment for chemotherapyrelated

anemia in children. Pediatrics 1999; 103:1-4.

Ray-Coquard I, dkk. Anaemia and cancer. Elect J Oncol

; 1:1-16.

Estrin JT, Shocket L, Kregenow R, Henry DH. A retrospective

review of blood transfusions in cancer patients

with anemia. Oncologist 1999; 4:318-24.

Dunst J. The use of epoetin alfa to increase and maintain

Hb levels during radiotherapy. Semin oncol 2001;

(suppl 8):42-8.

Harrison LB, dkk. Impact of tumor hypoxia and anemia

on radiation therapy outcomes. Oncologist 2002;

:492-508.

Brown JM. The hypoxic cell: a target for selective cancer

therapy-eighteenth Bruce F. Cain memorial award

lecture. Cancer res 1999; 59:5863-70.

Sobrero A, Puglisi F, Guglielmi A, Belvedere O, Aprile

G, Ramello M, dkk. Fatigue: a main component of anemia

symptomatology. Semin oncol 2001; 28(suppl

:15-8.

Vaupel P, Kelleher DK, Hockel M. Oxygenation status

of malignant tumors: phatogenesis of hypoxia and significance

for tumor therapy. Semin oncol 2001; 28(suppl

:29-35.

National comprehensive cancer network. Cancer and

treatment-related anemia. Practice guidelines in oncology-

version 1. USA, 2002.

Seidenfeld J, Piper M, Flamm C, Hasselblad V, Armitage

JO, Bennett CL, dkk. Epoetin treatment of anemia associated

with cancer therapy: a systematic review and

meta-analysis of controlled clinical trials. J Natl Cancer

Inst 2001; 93:1204-14.

Abels RI, Larholt KM, Krantz KD, Bryant EC. Recombinant

human erythropoietin for the treatment of the

anemia of cancer. Oncologist 1996; 1:140-50.




DOI: http://dx.doi.org/10.14238/sp6.4.2005.176-81

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc-sa4.footer##

Informasi Editorial:
Badan Penerbit Ikatan Dokter Anak Indonesia
Jl. Salemba I No 5, Jakarta 10430, Indonesia
Phone/Fax: +62-21-3912577
Email: editorial [at] saripediatri.org

Lisensi Creative Commons
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.